Literature DB >> 19291589

Prescribing behaviour after the introduction of decentralized drug budgets: is there an association with employer and type of care facility?

Karolina Andersson1, Anders Carlsten, Tove Hedenrud.   

Abstract

OBJECTIVE: To analyse whether prescribing patterns changed after introduction of drug budgets and whether there is an association between drug prescribing patterns and the type of employer and care facility.
METHODS: Data analysed encompassed information on dispensed medicines, by workplaces, prescribed in the Region Vastra Gotaland, Sweden, for the years 2003 and 2006. Workplaces (n = 969) were categorized according to type of employer and type of care facility. Five prescribing indicators reflecting goals for cost-containing prescribing in Region Vastra Gotaland were assessed. Changes over time and differences between different types of employer and care facility were analysed by Mann-Whitney tests.
RESULTS: In 2003, workplaces with a public employer had a significantly higher adherence to three of the prescribing indicators compared with private practitioners. Two of these differences remained in 2006. In 2003, none of the prescribing indicators differed between primary care and other care facilities. Three years later workplaces in primary care had a significantly higher adherence to three of the prescribing indicators than other care facilities. There was a statistically significant difference in change between 2003 and 2006 between primary care and other care facilities; there were no differences in change between workplaces with public and private employers.
CONCLUSIONS: Adherence to three of the prescribing indicators increased after the introduction of decentralized drug budgets. Workplaces with a public employer showed greater adherence to two of the prescribing indicators than private sector workplaces.

Mesh:

Substances:

Year:  2009        PMID: 19291589      PMCID: PMC3410459          DOI: 10.1080/02813430902793225

Source DB:  PubMed          Journal:  Scand J Prim Health Care        ISSN: 0281-3432            Impact factor:   2.581


  16 in total

1.  Decentralized responsibility for costs of outpatient prescription pharmaceuticals in Sweden. Assessment of models for decentralized financing of subsidies from a management perspective.

Authors:  Gina Bergström; Ingvar Karlberg
Journal:  Health Policy       Date:  2006-08-30       Impact factor: 2.980

2.  The application of prescribing indicators to a primary care prescription database in Ireland.

Authors:  D Williams; K Bennett; J Feely
Journal:  Eur J Clin Pharmacol       Date:  2005-02-12       Impact factor: 2.953

3.  The impact of decentralised drug-budgets in Sweden - a survey of physicians' attitudes towards costs and cost-effectiveness.

Authors:  Sandra Jansson; Anders Anell
Journal:  Health Policy       Date:  2005-07-19       Impact factor: 2.980

4.  [Quality indicators for drug prescribing--the situation in Sweden].

Authors:  Björn Wettermark; Göran Tomson; Ulf Bergman
Journal:  Lakartidningen       Date:  2006 Nov 15-21

5.  Physicians' opinions and experiences of the Pharmaceutical Benefits Reform.

Authors:  Karolina Andersson; Tove Jörgensen; Anders Carlsten
Journal:  Scand J Public Health       Date:  2006       Impact factor: 3.021

6.  Do policy changes in the pharmaceutical reimbursement schedule affect drug expenditures? Interrupted time series analysis of cost, volume and cost per volume trends in Sweden 1986-2002.

Authors:  Karolina Andersson; Max Gustav Petzold; Christian Sonesson; Knut Lönnroth; Anders Carlsten
Journal:  Health Policy       Date:  2006-02-13       Impact factor: 2.980

7.  GPs' thoughts on prescribing medication and evidence-based knowledge: the benefit aspect is a strong motivator. A descriptive focus group study.

Authors:  Ingmarie Skoglund; Kerstin Segesten; Cecilia Björkelund
Journal:  Scand J Prim Health Care       Date:  2007-06       Impact factor: 2.581

8.  Family physicians and generic drugs: a study of recognition, information sources, prescribing attitudes, and practices.

Authors:  A D Bower; G L Burkett
Journal:  J Fam Pract       Date:  1987-06       Impact factor: 0.493

9.  Medical speciality and pattern of medicines prescription.

Authors:  A Vallano; E Montané; J M Arnau; X Vidal; C Pallarés; M Coll; J R Laporte
Journal:  Eur J Clin Pharmacol       Date:  2004-10-16       Impact factor: 2.953

10.  Physician and practice characteristics associated with the early utilization of new prescription drugs.

Authors:  Robyn Tamblyn; Peter McLeod; James A Hanley; Nadyne Girard; Jeremiah Hurley
Journal:  Med Care       Date:  2003-08       Impact factor: 2.983

View more
  6 in total

1.  Should hospital pharmacy drug budgets be the responsibility of each individual department in an institution, or should such budgets be controlled centrally by the pharmacy department?

Authors: 
Journal:  Can J Hosp Pharm       Date:  2010-07

2.  Primary care physicians' adoption of new drugs is not associated with their clinical interests: a pharmacoepidemiologic study.

Authors:  Torben Dybdahl; Jens Søndergaard; Jakob Kragstrup; Ivar Sønbø Kristiansen; Morten Andersen
Journal:  Scand J Prim Health Care       Date:  2011-04-21       Impact factor: 2.581

3.  The impact of physician-level drug budgets on prescribing behavior.

Authors:  Katharina Elisabeth Fischer; Taika Koch; Karel Kostev; Tom Stargardt
Journal:  Eur J Health Econ       Date:  2017-02-13

4.  Income differences in the type of antihypertensive medicines used in ambulatory settings in Finland: a register-based study.

Authors:  Härkönen Mirva; Timonen Johanna; Tervola Jussi; Katri Aaltonen
Journal:  Eur J Clin Pharmacol       Date:  2015-07-31       Impact factor: 2.953

Review 5.  Pharmaceutical policies: effects of financial incentives for prescribers.

Authors:  Arash Rashidian; Amir-Houshang Omidvari; Yasaman Vali; Heidrun Sturm; Andrew D Oxman
Journal:  Cochrane Database Syst Rev       Date:  2015-08-04

6.  GPs' negotiation strategies regarding sick leave for subjective health complaints.

Authors:  Stein Nilsen; Kirsti Malterud; Erik L Werner; Silje Maeland; Liv Heide Magnussen
Journal:  Scand J Prim Health Care       Date:  2015-01-20       Impact factor: 2.581

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.